YAP oncogene overexpression supercharges colon cancer proliferation

References

• Sudol M. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene 1994; 9:2145 - 2152; PMID: 8035999
   PubMed Web of Science ®Google Scholar
• Bork P, Sudol M. The WW domain: a signalling site in dystrophin?. Trends Biochem Sci 1994; 19:531 - 533; PMID: 7846762; http://dx.doi.org/10.1016/0968-0004(94)90053-1
   PubMed Web of Science ®Google Scholar
• Chen HI, Sudol M. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad Sci USA 1995; 92:7819 - 7823; PMID: 7644498; http://dx.doi.org/10.1073/pnas.92.17.7819
   PubMed Web of Science ®Google Scholar
• Komuro A, Nagai M, Navin NE, Sudol M. WW domain-containing protein YAP associates with ErbB4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem 2003; 278:33334 - 33341; PMID: 12807903; http://dx.doi.org/10.1074/jbc.M305597200
   PubMed Web of Science ®Google Scholar
• Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J 1999; 18:2551 - 2562; PMID: 10228168; http://dx.doi.org/10.1093/emboj/18.9.2551
   PubMed Web of Science ®Google Scholar
• Vassilev A, Kaneko KJ, Shu H, Zhao Y, DePamphilis ML. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev 2001; 15:1229 - 1241; http://dx.doi.org/10.1101/gad.888601; PMID: 11358867
   PubMed Web of Science ®Google Scholar
• Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 2005; 122:421 - 434; PMID: 16096061; http://dx.doi.org/10.1016/j.cell.2005.06.007
   PubMed Web of Science ®Google Scholar
• Pan D. Hippo signaling in organ size control. Genes Dev 2007; 21:886 - 897; PMID: 17437995; http://dx.doi.org/10.1101/gad.1536007
   PubMed Web of Science ®Google Scholar
• Halder G, Johnson RL. Hippo signaling: growth control and beyond. Development 2011; 138:9 - 22; PMID: 21138973; http://dx.doi.org/10.1242/dev.045500
   PubMed Web of Science ®Google Scholar
• Zhang L, Ren F, Zhang Q, Chen Y, Wang B, Jiang J. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell 2008; 14:377 - 387; http://dx.doi.org/10.1016/j.devcel.2008.01.006; PMID: 18258485
   PubMed Web of Science ®Google Scholar
• Wu S, Liu Y, Zheng Y, Dong J, Pan D. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell 2008; 14:388 - 398; PMID: 18258486
   PubMed Web of Science ®Google Scholar
• Goulev Y, Fauny JD, Gonzalez-Marti B, Flagiello D, Silber J, Zider A. SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila. Curr Biol 2008; 18:435 - 441; PMID: 18313299; http://dx.doi.org/10.1016/j.cub.2008.02.034
   PubMed Web of Science ®Google Scholar
• Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007; 21:2747 - 2761; http://dx.doi.org/10.1101/gad.1602907; PMID: 17974916
   PubMed Web of Science ®Google Scholar
• Oh H, Irvine KD. In vivo regulation of Yorkie phosphorylation and localization. Development 2008; 135:1081 - 1088; http://dx.doi.org/10.1242/dev.015255; PMID: 18256197
   PubMed Web of Science ®Google Scholar
• Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 2008; 28:2426 - 2436; PMID: 18227151; http://dx.doi.org/10.1128/MCB.01874-07
   PubMed Web of Science ®Google Scholar
• Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 2011; 147:759 - 772; PMID: 22078877; http://dx.doi.org/10.1016/j.cell.2011.09.048
   PubMed Web of Science ®Google Scholar
• Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F, et al. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev 2011; 25:2594 - 2609; PMID: 22190458; http://dx.doi.org/10.1101/gad.176800.111
   PubMed Web of Science ®Google Scholar
• Strano S, Monti O, Pediconi N, Baccarini A, Fontemaggi G, Lapi E, et al. The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage. Mol Cell 2005; 18:447 - 459; PMID: 15893728; http://dx.doi.org/10.1016/j.molcel.2005.04.008
   PubMed Web of Science ®Google Scholar
• Lapi E, Di Agostino S, Donzelli S, Gal H, Domany E, Rechavi G, et al. PML YAP and p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell 2008; 32:803 - 814; PMID: 19111660; http://dx.doi.org/10.1016/j.molcel.2008.11.019
   PubMed Web of Science ®Google Scholar
• Levy D, Adamovich Y, Reuven N, Shaul Y. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell 2008; 29:350 - 361; PMID: 18280240; http://dx.doi.org/10.1016/j.molcel.2007.12.022
   PubMed Web of Science ®Google Scholar
• Zaidi SK, Sullivan AJ, Medina R, Ito Y, van Wijnen AJ, Stein JL, et al. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J 2004; 23:790 - 799; http://dx.doi.org/10.1038/sj.emboj.7600073; PMID: 14765127
   PubMed Web of Science ®Google Scholar
• Vitolo MI, Anglin IE, Mahoney WM Jr, Renoud KJ, Gartenhaus RB, Bachman KE, et al. The RUNX2 transcription factor cooperates with the YES-associated protein, YAP65, to promote cell transformation. Cancer Biol Ther 2007; 6:856 - 863; PMID: 17438369; http://dx.doi.org/10.4161/cbt.6.6.4241
   PubMed Web of Science ®Google Scholar
• Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC, et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA 2006; 103:12405 - 12410; http://dx.doi.org/10.1073/pnas.0605579103; PMID: 16894141
   PubMed Web of Science ®Google Scholar
• Yuan M, Tomlinson V, Lara R, Holliday D, Chelala C, Harada T, et al. Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ 2008; 15:1752 - 1759; PMID: 18617895; http://dx.doi.org/10.1038/cdd.2008.108
   PubMed Web of Science ®Google Scholar
• Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 2007; 17:2054 - 2060; PMID: 17980593; http://dx.doi.org/10.1016/j.cub.2007.10.039
   PubMed Web of Science ®Google Scholar
• Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007; 130:1120 - 1133; http://dx.doi.org/10.1016/j.cell.2007.07.019; PMID: 17889654
   PubMed Web of Science ®Google Scholar
• Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006; 125:1253 - 1267; http://dx.doi.org/10.1016/j.cell.2006.05.030; PMID: 16814713
   PubMed Web of Science ®Google Scholar
• Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y, et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 2009; 16:425 - 438; http://dx.doi.org/10.1016/j.ccr.2009.09.026; PMID: 19878874
   PubMed Web of Science ®Google Scholar
• Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L, et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA 2010; 107:1431 - 1436; http://dx.doi.org/10.1073/pnas.0911409107; PMID: 20080598
   PubMed Web of Science ®Google Scholar
• Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q, et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA 2010; 107:1437 - 1442; PMID: 20080689; http://dx.doi.org/10.1073/pnas.0911427107
   PubMed Web of Science ®Google Scholar
• Avruch J, Zhou D, Fitamant J, Bardeesy N. Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development. Br J Cancer 2011; 104:24 - 32; http://dx.doi.org/10.1038/sj.bjc.6606011; PMID: 21102585
   PubMed Web of Science ®Google Scholar
• Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D, et al. Expression of Yes-associated protein in common solid tumors. Hum Pathol 2008; 39:1582 - 1589; http://dx.doi.org/10.1016/j.humpath.2008.04.012; PMID: 18703216
   PubMed Web of Science ®Google Scholar
• Zhang X, George J, Deb S, Degoutin JL, Takano EA, Fox SB, et al. AOCS Study group. The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene 2011; 30:2810 - 2822; http://dx.doi.org/10.1038/onc.2011.8; PMID: 21317925
   PubMed Web of Science ®Google Scholar
• Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT, Zender L, et al. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 2009; 115:4576 - 4585; http://dx.doi.org/10.1002/cncr.24495; PMID: 19551889
   PubMed Web of Science ®Google Scholar
• Wang Y, Dong Q, Zhang Q, Li Z, Wang E, Qiu X. Overexpression of yes-associated protein contributes to progression and poor prognosis of non-smallcell lung cancer. Cancer Sci 2010; 101:1279 - 1285; PMID: 20219076; http://dx.doi.org/10.1111/j.13497006.2010.01511.x
   PubMed Web of Science ®Google Scholar
• Muramatsu T, Imoto I, Matsui T, Kozaki K, Haruki S, Sudol M, et al. YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis 2011; 32:389 - 398; PMID: 21112960; http://dx.doi.org/10.1093/carcin/bgq254
   PubMed Web of Science ®Google Scholar
• van der Flier LG, Clevers H. Stem cells, self-renewal and differentiation in the intestinal epithelium. Annu Rev Physiol 2009; 71:241 - 260; PMID: 18808327; http://dx.doi.org/10.1146/annurev.physiol.010908.163145
   PubMed Web of Science ®Google Scholar
• Zhou D, Zhang Y, Wu H, Barry E, Yin Y, Lawrence E, et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA 2011; 108:1312 - 1320; PMID: 22042863; http://dx.doi.org/10.1073/pnas.1110428108
   PubMed Web of Science ®Google Scholar
• Cai J, Zhang N, Zheng Y, de Wilde RF, Maitra A, Pan D. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 2010; 24:2383 - 2388; http://dx.doi.org/10.1101/gad.1978810; PMID: 21041407
   PubMed Web of Science ®Google Scholar
• Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J, et al. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 2010; 24:1106 - 1118; http://dx.doi.org/10.1101/gad.1903310; PMID: 20516196
   PubMed Web of Science ®Google Scholar
• Cao X, Pfaff SL, Gage FH. YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev 2008; 22:3320 - 3334; http://dx.doi.org/10.1101/gad.1726608; PMID: 19015275
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 213:286 - 300; http://dx.doi.org/10.1002/jcp.21172; PMID: 17559071
   PubMed Web of Science ®Google Scholar
• Yanger K, Stanger BZ. Facultative stem cells in liver and pancreas: fact and fancy. Dev Dyn 2011; 240:521 - 529; http://dx.doi.org/10.1002/dvdy.22561; PMID: 21312313
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang L, He Q, Feng X, Zhu J, Xu Z, et al. Differences in Yes-associated protein and mRNA levels in regenerating liver and hepatocellular carcinoma. Mol Med Report 2012; 5:410 - 414; http://dx.doi.org/10.3892/mmr.2011.640; PMID: 22012126
   PubMed Web of Science ®Google Scholar
• Barker N, Bartfeld S, Clevers H. Tissue-resident adult stem cell populations of rapidly self-renewing organs. Cell Stem Cell 2010; 7:656 - 670; PMID: 21112561; http://dx.doi.org/10.1016/j.stem.2010.11.016
   PubMed Web of Science ®Google Scholar
• Fre S, Pallavi SK, Huyghe M, Laé M, Janssen KP, Robine S, et al. Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc Natl Acad Sci USA 2009; 106:6309 - 6314; http://dx.doi.org/10.1073/pnas.0900427106; PMID: 19251639
   PubMed Web of Science ®Google Scholar
• Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL, et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 2011; 332:458 - 461; PMID: 21512031; http://dx.doi.org/10.1126/science.1199010
   PubMed Web of Science ®Google Scholar
• Fernandez LA, Northcott PA, Dalton J, Fraga C, Ellison D, Angers S, et al. YAP1 is amplified and upregulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev 2009; 23:2729 - 2741; PMID: 19952108; http://dx.doi.org/10.1101/gad.1824509
   PubMed Web of Science ®Google Scholar
• Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 2010; 24:72 - 85; http://dx.doi.org/10.1101/gad.1843810; PMID: 20048001
   PubMed Web of Science ®Google Scholar
• Wu S, Huang J, Dong J, Pan D. hippo encodes a Ste20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 2003; 114:445 - 456; PMID: 12941273; http://dx.doi.org/10.1016/S0092-8674(03)00549-X
   PubMed Web of Science ®Google Scholar
• Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D, et al. Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell 2011; 144:782 - 795; PMID: 21376238; http://dx.doi.org/10.1016/j.cell.2011.02.031
   PubMed Web of Science ®Google Scholar
• Kim NG, Koh E, Chen X, Gumbiner BM. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci USA 2011; 108:11930 - 11935; PMID: 21730131; http://dx.doi.org/10.1073/pnas.1103345108
   PubMed Web of Science ®Google Scholar
• Grusche FA, Richardson HE, Harvey KF. Upstream regulation of the hippo size control pathway. Curr Biol 2010; 20:574 - 582; PMID: 20619814; http://dx.doi.org/10.1016/j.cub.2010.05.023
   PubMed Web of Science ®Google Scholar
• Yin M, Zhang L. Hippo signaling: a hub of growth control, tumor suppression and pluripotency maintenance. J Genet Genomics 2011; 38:471 - 481; http://dx.doi.org/10.1016/j.jgg.2011.09.009; PMID: 22035868
   PubMed Web of Science ®Google Scholar
• Enomoto M, Igaki T. Deciphering tumor-suppressor signaling in flies: genetic link between Scribble/Dlg/Lgl and the Hippo pathways. J Genet Genomics 2011; 38:461 - 470; http://dx.doi.org/10.1016/j.jgg.2011.09.005; PMID: 22035867
   PubMed Web of Science ®Google Scholar
• Staley BK, Irvine KD. Hippo signaling in Drosophila: recent advances and insights. Dev Dyn 2012; 241:3 - 15; http://dx.doi.org/10.1002/dvdy.22723; PMID: 22174083
   PubMed Web of Science ®Google Scholar
• Badouel C, Gardano L, Amin N, Garg A, Rosenfeld R, Le Bihan T, et al. The FERM-domain protein Expanded regulates Hippo pathway activity via direct interactions with the transcriptional activator Yorkie. Dev Cell 2009; 16:411 - 420; PMID: 19289086; http://dx.doi.org/10.1016/j.devcel.2009.01.010
   PubMed Web of Science ®Google Scholar
• Oh H, Reddy BV, Irvine KD. Phosphorylationindependent repression of Yorkie in Fat-Hippo signaling. Dev Biol 2009; 335:188 - 197; http://dx.doi.org/10.1016/j.ydbio.2009.08.026; PMID: 19733165
   PubMed Web of Science ®Google Scholar
• Angus L, Moleirinho S, Herron L, Sinha A, Zhang X, Niestrata M, et al. Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP. Oncogene 2011; PMID: 21666719
   PubMed Web of Science ®Google Scholar
• Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007; 21:2747 - 2761; PMID: 17974916; http://dx.doi.org/10.1101/gad.1602907
   PubMed Web of Science ®Google Scholar
• Silvis MR, Kreger BT, Lien WH, Klezovitch O, Rudakova GM, Camargo FD, et al. α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci Signal 2011; 4:33; http://dx.doi.org/10.1126/scisignal.2001823; PMID: 21610251
   PubMed Web of Science ®Google Scholar
• Avruch J, Xavier R, Bardeesy N, Zhang XF, Praskova M, Zhou D, et al. Rassf family of tumor suppressor polypeptides. J Biol Chem 2009; 284:1100 - 1115; http://dx.doi.org/10.1074/jbc.R800073200; PMID: 19091744
   PubMed Web of Science ®Google Scholar
• Richter AM, Pfeifer GP, Dammann RH. The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim Biophys Acta 2009; 1796:114 - 128; PMID: 19344752
   PubMed Web of Science ®Google Scholar
• Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD. Zyxin links fat signaling to the hippo pathway. PLoS Biol 2011; 9:1000624; PMID: 21666802; http://dx.doi.org/10.1371/journal.pbio.1000624
   PubMed Web of Science ®Google Scholar
• Yu J, Zheng Y, Dong J, Klusza S, Deng WM, Pan D. Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell 2010; 18:288 - 299; http://dx.doi.org/10.1016/j.devcel.2009.12.012; PMID: 20159598
   PubMed Web of Science ®Google Scholar
• Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N. Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell 2010; 18:300 - 308; http://dx.doi.org/10.1016/j.devcel.2009.12.011; PMID: 20159599
   PubMed Web of Science ®Google Scholar
• Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H. The WW domain protein Kibra acts upstream of Hippo in Drosophila 2010; 18:309 - 316
   Google Scholar
• Vigneron AM, Ludwig RL, Vousden KH. Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP. Genes Dev 2010; 24:2430 - 439; http://dx.doi.org/10.1101/gad.1954310; PMID: 21041411
   PubMed Web of Science ®Google Scholar
• Aylon Y, Ofir-Rosenfeld Y, Yabuta N, Lapi E, Nojima H, Lu X, et al. The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1. Genes Dev 2010; 24:2420 - 429; http://dx.doi.org/10.1101/gad.1954410; PMID: 21041410
   PubMed Web of Science ®Google Scholar
• Das Thakur M, Feng Y, Jagannathan R, Seppa MJ, Skeath JB, Longmore GD. Ajuba LIM proteins are negative regulators of the Hippo signaling pathway. Curr Biol 2010; 20:657 - 662; PMID: 20303269; http://dx.doi.org/10.1016/j.cub.2010.02.035
   PubMed Web of Science ®Google Scholar
• Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q, et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 2011; 25:51 - 63; http://dx.doi.org/10.1101/gad.2000111; PMID: 21205866
   PubMed Web of Science ®Google Scholar
• Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 2011; 286:7018 - 7026; http://dx.doi.org/10.1074/jbc.C110.212621; PMID: 21224387
   PubMed Web of Science ®Google Scholar
• Oka T, Schmitt AP, Sudol M. Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP. Oncogene 2012; 31:128 - 134; http://dx.doi.org/10.1038/onc.2011.216; PMID: 21685940
   PubMed Web of Science ®Google Scholar
• Paramasivam M, Sarkeshik A, Yates JR 3rd, Fernandes MJ, McCollum D. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell 2011; 22:3725 - 3733; http://dx.doi.org/10.1091/mbc.E11-04-0300; PMID: 21832154
   PubMed Web of Science ®Google Scholar
• Sekido Y. Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation. Pathol Int 2011; 61:331 - 344; PMID: 21615608; http://dx.doi.org/10.1111/j.1440-827.2011.02666.x
   PubMed Web of Science ®Google Scholar
• Zhao B, Ye X, Yu J, Li L, Li W, Li S, et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 2008; 22:1962 - 1971; http://dx.doi.org/10.1101/gad.1664408; PMID: 18579750
   PubMed Web of Science ®Google Scholar
• Urtasun R, Latasa MU, Demartis MI, Balzani S, Goñi S, Garcia-Irigoyen O, et al. Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation. Hepatology 2011; 54:2149 - 2158; http://dx.doi.org/10.1002/hep.24587; PMID: 21800344
   PubMed Web of Science ®Google Scholar
• Zhang J, Ji JY, Yu M, Overholtzer M, Smolen GA, Wang R, et al. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat Cell Biol 2009; 11:1444 - 1450; http://dx.doi.org/10.1038/ncb1993; PMID: 19935651
   PubMed Web of Science ®Google Scholar
• Kemper K, Grandela C, Medema JP. Molecular identification and targeting of colorectal cancer stem cells. Oncotarget 2010; 1:387 - 395; PMID: 21311095
   PubMed Web of Science ®Google Scholar
• Sikandar S, Dizon D, Shen X, Li Z, Besterman J, Lipkin SM. The class I HDAC inhibitor MGCD0103 induces cell cycle arrest and apoptosis in colon cancer initiating cells by upregulating Dickkopf-1 and non-canonical Wnt signaling. Oncotarget 2010; 1:596 - 605; PMID: 21317455
   PubMed Web of Science ®Google Scholar
• Hart LS, Dolloff NG, Dicker DT, Koumenis C, Christensen JG, Grimberg A, et al. Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab. Cell Cycle 2011; 10:2331 - 2338; PMID: 21720213; http://dx.doi.org/10.4161/cc.10.14.16418
   PubMed Web of Science ®Google Scholar